Health
FDA grants Pasithea ALS drug rare-disease status
FDA grants Pasithea ALS drug PAS-004 rare-disease status on June 3, 2026, accelerating its development for the devastati…
James Whitfield·
5 articles
FDA grants Pasithea ALS drug PAS-004 rare-disease status on June 3, 2026, accelerating its development for the devastati…
The Supreme Court temporarily restores abortion pill access nationwide, preserving mifepristone availability by mail and…
US Food and Drug Administration blocked publication of studies confirming shingles and COVID-19 vaccine safety, raising…
FDA proposes a new ultra-rare disease pathway for treatment approval on May 4, 2026, aiming to streamline access for pat…
President Trump fast tracks psychedelics for mental health, signing an executive order to expedite review, signaling a m…